MXPA03011226A - Imidazol sustituido con arilazo para el tratamiento de incontinencia urinaria por estres. - Google Patents
Imidazol sustituido con arilazo para el tratamiento de incontinencia urinaria por estres.Info
- Publication number
- MXPA03011226A MXPA03011226A MXPA03011226A MXPA03011226A MXPA03011226A MX PA03011226 A MXPA03011226 A MX PA03011226A MX PA03011226 A MXPA03011226 A MX PA03011226A MX PA03011226 A MXPA03011226 A MX PA03011226A MX PA03011226 A MXPA03011226 A MX PA03011226A
- Authority
- MX
- Mexico
- Prior art keywords
- arylazo
- treatment
- urinary incontinence
- substituted imidazole
- stress urinary
- Prior art date
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title abstract 4
- 206010066218 Stress Urinary Incontinence Diseases 0.000 title abstract 2
- 150000002460 imidazoles Chemical class 0.000 title abstract 2
- 230000001800 adrenalinergic effect Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0114008.6A GB0114008D0 (en) | 2001-06-08 | 2001-06-08 | New therapautic use |
| PCT/GB2002/002635 WO2002100414A1 (en) | 2001-06-08 | 2002-06-07 | Arylazo-substituted imidazole for the treatment of stress urinary incontinence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03011226A true MXPA03011226A (es) | 2004-03-26 |
Family
ID=9916211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03011226A MXPA03011226A (es) | 2001-06-08 | 2002-06-07 | Imidazol sustituido con arilazo para el tratamiento de incontinencia urinaria por estres. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20040242547A1 (enExample) |
| EP (1) | EP1399167A1 (enExample) |
| JP (1) | JP2005500285A (enExample) |
| KR (1) | KR20040030654A (enExample) |
| CN (1) | CN1234367C (enExample) |
| AU (1) | AU2002311445B2 (enExample) |
| BR (1) | BR0210195A (enExample) |
| CA (1) | CA2449957A1 (enExample) |
| GB (1) | GB0114008D0 (enExample) |
| MX (1) | MXPA03011226A (enExample) |
| RU (1) | RU2004100228A (enExample) |
| WO (1) | WO2002100414A1 (enExample) |
| ZA (1) | ZA200309473B (enExample) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6056123B2 (ja) * | 1979-07-30 | 1985-12-09 | 持田製薬株式会社 | 浮腫・低血圧・心不全および粘膜充血治療用剤 |
| DE19514579A1 (de) * | 1995-04-20 | 1996-10-24 | Boehringer Ingelheim Kg | Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz |
| US6323231B1 (en) * | 2000-02-17 | 2001-11-27 | Abbott Laboratories | Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence |
-
2001
- 2001-06-08 GB GBGB0114008.6A patent/GB0114008D0/en not_active Ceased
-
2002
- 2002-06-07 WO PCT/GB2002/002635 patent/WO2002100414A1/en not_active Ceased
- 2002-06-07 MX MXPA03011226A patent/MXPA03011226A/es unknown
- 2002-06-07 AU AU2002311445A patent/AU2002311445B2/en not_active Ceased
- 2002-06-07 EP EP02738362A patent/EP1399167A1/en not_active Withdrawn
- 2002-06-07 BR BR0210195-5A patent/BR0210195A/pt not_active IP Right Cessation
- 2002-06-07 JP JP2003503235A patent/JP2005500285A/ja not_active Withdrawn
- 2002-06-07 CA CA002449957A patent/CA2449957A1/en not_active Abandoned
- 2002-06-07 CN CNB028129687A patent/CN1234367C/zh not_active Expired - Fee Related
- 2002-06-07 KR KR10-2003-7015978A patent/KR20040030654A/ko not_active Withdrawn
- 2002-06-07 ZA ZA200309473A patent/ZA200309473B/xx unknown
- 2002-06-07 RU RU2004100228/15A patent/RU2004100228A/ru not_active Application Discontinuation
- 2002-06-07 US US10/478,977 patent/US20040242547A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1234367C (zh) | 2006-01-04 |
| JP2005500285A (ja) | 2005-01-06 |
| ZA200309473B (en) | 2005-03-23 |
| RU2004100228A (ru) | 2005-06-10 |
| EP1399167A1 (en) | 2004-03-24 |
| AU2002311445B2 (en) | 2005-08-25 |
| CA2449957A1 (en) | 2002-12-19 |
| WO2002100414A1 (en) | 2002-12-19 |
| CN1541099A (zh) | 2004-10-27 |
| GB0114008D0 (en) | 2001-08-01 |
| US20040242547A1 (en) | 2004-12-02 |
| BR0210195A (pt) | 2004-07-27 |
| KR20040030654A (ko) | 2004-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY135766A (en) | Quinolinones and naphthyridinones for treating inflammatory diseases | |
| MXPA02007099A (es) | Compuestos de tiazola, imidazola y oxazola y tratamientos de desordenes asociados con la maduracion de la proteina. | |
| MY135477A (en) | 2-(2,6-dichlorophenyl)-diarylimidazoles | |
| MY135333A (en) | Modulators of the glucocorticoid receptor | |
| MX342777B (es) | Inhibidores tnfa para usarse en el tratamiento de trastornos relacionados con tnfa. | |
| AU3831301A (en) | Method for treating ocular pain | |
| PL356846A1 (en) | Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase | |
| MXPA03007140A (es) | Derivados de carbolina. | |
| MXPA03010327A (es) | USO DE OSTEOPONTINA PARA TRATAMIENTO Y/O PREVENCIoN DE ENFERMEDADES NEUROLoGICAS. | |
| MXPA03010586A (es) | N-[(1s)-1,2,3,4-tertrahidro-1-naftalenil benzamidas trisubtituidas, las cuales inhiben receptores que contienen p2x2/3. | |
| AU2001260880A1 (en) | Pharmaceutical compounds for treating copd | |
| ZA200307731B (en) | Use of selective COX-2inhibitors for the treatment of urinary incontinence. | |
| GB2442893A (en) | Method of dynamically assigning mobility configuration parameters for mobile entities | |
| AU2003214273A1 (en) | Improved system for the treatment of stress urinary incontinence | |
| DE50213926D1 (de) | Portsystem für einen perkutan implantierten port | |
| MXPA03001962A (es) | Metodo para tratar alergias utilizando pirazoles sustituidos. | |
| AU5628800A (en) | Substituted benzamide inhibitors of rhinovirus 3c protease | |
| MXPA03010406A (es) | Tratamiento novedoso para el desorden obsesivo-compulsivo (ocd) y desordenes relacionados con ocd. | |
| PL377176A1 (pl) | N-Sulfonylo-4-metylenoamino-3-hydroksy-2-pirydony | |
| PL366051A1 (en) | Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence | |
| MY120578A (en) | Method for treating glaucoma | |
| AU2002231777A1 (en) | Use of mglur5 antagonists for the treatment of pruritic conditions | |
| MXPA03011226A (es) | Imidazol sustituido con arilazo para el tratamiento de incontinencia urinaria por estres. | |
| DE60011677D1 (en) | Tryptase-inhibitoren | |
| MXPA03006742A (es) | Uso de buprenorfina para la terapia de la incontinencia urinaria. |